These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33435572)

  • 21. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
    Qin XY; Suzuki H; Honda M; Okada H; Kaneko S; Inoue I; Ebisui E; Hashimoto K; Carninci P; Kanki K; Tatsukawa H; Ishibashi N; Masaki T; Matsuura T; Kagechika H; Toriguchi K; Hatano E; Shirakami Y; Shiota G; Shimizu M; Moriwaki H; Kojima S
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4969-4974. PubMed ID: 29686061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventive use of retinoids for occurrence of liver neoplasm].
    Muto Y
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2032-7. PubMed ID: 8586927
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
    Shimizu M; Imai K; Takai K; Moriwaki H
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros.
    Masuzaki R; Yoshida H; Omata M
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S281-6. PubMed ID: 20547315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma.
    Wang L; Levin MS
    Gastroenterology; 2005 Jan; 128(1):228-31. PubMed ID: 15633140
    [No Abstract]   [Full Text] [Related]  

  • 26. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.
    Takami T; Yamasaki T; Saeki I; Matsumoto T; Suehiro Y; Sakaida I
    World J Gastroenterol; 2016 Aug; 22(32):7252-63. PubMed ID: 27621572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.
    Sakai H; Shirakami Y; Shimizu M
    World J Gastroenterol; 2016 Jan; 22(1):394-406. PubMed ID: 26755885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation--a systematic review and meta-analysis.
    Chu KJ; Lai EC; Yao XP; Zhang HW; Lau WY; Fu XH; Lu CD; Shi J; Cheng SQ
    Asian J Surg; 2010 Jul; 33(3):120-6. PubMed ID: 21163409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoids and cancer chemoprevention.
    Moriwaki H; Muto T
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():317-20. PubMed ID: 1338446
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthetic retinoids for the secondary prevention of hepatocellular carcinoma.
    Shafritz DA
    N Engl J Med; 1996 Jun; 334(24):1600-1. PubMed ID: 8628344
    [No Abstract]   [Full Text] [Related]  

  • 32. Retinoid roles in blocking hepatocellular carcinoma.
    Shirakami Y; Sakai H; Shimizu M
    Hepatobiliary Surg Nutr; 2015 Aug; 4(4):222-8. PubMed ID: 26311412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of hepatocellular carcinoma in chronic hepatitis C.
    Morgan TR
    Recent Results Cancer Res; 2011; 188():85-99. PubMed ID: 21253791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoids and their target genes in liver functions and diseases.
    Shiota G; Kanki K
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():33-7. PubMed ID: 23855293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of hepatocellular carcinoma.
    Colombo M; Donato MF
    Semin Liver Dis; 2005; 25(2):155-61. PubMed ID: 15918144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of liver cancer.
    Guyton KZ; Kensler TW
    Curr Oncol Rep; 2002 Nov; 4(6):464-70. PubMed ID: 12354357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current strategies for chemoprevention of hepatocellular carcinoma.
    Okita K; Sakaida I; Hino K
    Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Suzuki K; Koyama H; Nakamura N; Kimura Y; Ogata A; Ikenuma H; Ishii H; Zhang MR; Kawamura K; Minamimoto T; Nagai Y; Katsuki H; Kimura T; Kimura N; Ichise M; Kato T; Ito K; Suzuki M
    Bioorg Med Chem Lett; 2023 Apr; 85():129212. PubMed ID: 36871703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant systemic drug therapy and recurrence of hepatocellular carcinoma following curative resection.
    Zhong Y; Liu B; Deng M; Xu R
    Drug Discov Ther; 2013 Aug; 7(4):164-6. PubMed ID: 24071579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.
    Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G
    J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.